A study led by researchers at Fred Hutchinson Cancer Research Center has found that a next-generation, high-speed DNA-decoding technology called high-throughput sequencing can detect the earliest signs of potential relapse in nearly twice the number of leukemia patients as compared to flow cytometry, the current gold standard for detecting minimal residual disease. The results of the study, led by Hutchinson Center computational biologist Harlan Robins, Ph.D., are reported in Science Translational Medicine...
Realtime Related Tweets
beyonce dance for you video asu football asu football arkansas lsu storage wars storage wars millionaire matchmaker
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.